After-Hours Stock Movers
DBV Technologies (NASDAQ:DBVT) 40% HIGHER; announced that its pivotal Phase 3 trial EPITOPE (EPIT in TOddlers with PEanut Allergy), assessing the safety and efficacy of Viaskin™ Peanut 250 µg for the treatment of peanut-allergic toddlers ages 1 to 3 years, met its primary endpoint.
Wintrust Financial Corporation (NASDAQ:WTFC) 5% LOWER; commenced an underwritten public offering of 2,700,000 shares of its common stock.
Smartsheet (NYSE:SMAR) 5% LOWER; reported Q1 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $168.3 million versus the consensus estimate of $162.56 million. Smartsheet sees Q2 2023 EPS of ($0.21)-($0.19), versus the consensus of ($0.17). Smartsheet sees Q2 2023 revenue of $180-181 million, versus the consensus of $179.5 million. Smartsheet sees FY2023 EPS of ($0.67)-($0.59), versus the consensus of ($0.66). Smartsheet sees FY2023 revenue of $756-761 million, versus the consensus of $752.6 million.
DocuSign (NASDAQ:DOCU) 4% HIGHER; announced an expansion of its global strategic partnership with Microsoft (NASDAQ:MSFT) to accelerate how people collaborate and come to agreement in the anywhere economy.
Affirm Holdings Inc (NASDAQ:AFRM) 2% LOWER; Wedbush initiates coverage with an Underperform rating and a price target of $15.00.
Novavax, Inc. (NASDAQ:NVAX) 1% HIGHER; announced the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21 to 0, with one abstention, to recommend that the FDA grant Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine (NVX-CoV2373) for individuals aged 18 years and over.